Cardiome Pharma To Axe Jobs - Quick Facts

7/9/2012 9:38 AM ET

Cardiome Pharma Corp. (CRME,COM.TO: Quote) said it is undertaking a significant workforce reduction, following the recently announced termination of Merck's development efforts relating to the vernakalant oral program. The workforce reduction eliminates all positions focused on internal research activities along with certain supporting functions. The personnel reduction would decrease the total number of employees by some 85%.

The company is likely to incur up to $5.0 million in severance and other charges related to this restructuring over the remainder of the year.

Previously, Cardiome Pharma had announced that one of Hunter's first tasks as interim CEO would be to review all current activities of the company with the immediate objective of optimizing the spend rate. Today's announcement reflects completion of this objective.

Click here to receive FREE breaking news email alerts for Cardiome Pharma and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 111 Articles

Editors Pick

Stocks Come Under Pressure Amid Worries About Fed - U.S. Commentary

After moving mostly higher over the course of morning trading on Wednesday, stocks have shown a notable move back to the downside in the afternoon. The major averages have pulled back well off their highs for the session and into negative territory. The major averages have moved roughly sideways in recent trading, lingering near their new lows for the session.

Immigration Reform Bill Clears Senate Judiciary Committee

Comprehensive immigration reform legislation took a step toward approval on Tuesday, as the members of the Senate Judiciary Committee voted to send the bill to the Senate floor. The Senate Judiciary Committee voted 13 to 5 in favor of the bill, with three Republicans joining with the panel's ten Democrats in voting to support the legislation.

U.S. Existing Home Sales Edge Up To Three-Year High In April

Existing home sales in the U.S. saw a modest increase in the month of April, according to a report released by the National Association of Realtors on Wednesday. NAR said existing home sales climbed 0.6 percent to a seasonally adjusted annual rate of 4.97 million in April from an upwardly revised 4.94 million in March.